TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Asker Healthcare Group AB ( (SE:ASKER) ) has issued an update.
Asker Healthcare Group announced it will release its interim report for January-June 2025 on July 22, followed by a webcast presentation featuring CEO Johan Falk and CFO Thomas Moss. This event allows investors, analysts, and media to engage with the company’s leadership, providing insights into Asker’s financial performance and strategic direction.
The most recent analyst rating on (SE:ASKER) stock is a Buy with a SEK100.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group is a European healthcare organization that partners with caregivers and patients to provide medical products and solutions. The company focuses on improving patient outcomes, reducing the total cost of care, and ensuring a sustainable value chain. It operates across 17 countries with over 4,000 employees and generates revenues of SEK 16 billion.
Average Trading Volume: 438,718
Current Market Cap: SEK41.1B
Find detailed analytics on ASKER stock on TipRanks’ Stock Analysis page.